Answers are grounded in this paper and cite their sources.
Irisin, initially described as a myokine, is widely distributed throughout the body and is released during physical exercise. It exerts beneficial effects on multiple tissues and, organs, and in systemic diseases, including neurological, metabolic, cardiovascular, pulmonary, and musculoskeletal disorders. Recent studies have highlighted the role of irisin receptors in various disease models and cell types, identifying integrin αV, particularly integrin αVβ5, as a key irisin-binding receptor. This review summarizes the current findings on irisin receptor biology and elucidates the mechanisms by which irisin mediates its effects via these receptors in various diseases. We propose that integrin αVβ5 receptors may represent promising therapeutic target for the treatment of diseases associated with exercise-induced irisin, offering a novel perspective for the alleviation of systemic diseases through exercise and rehabilitation. • Identified integrin αV, particularly integrin αVβ5, as the key functional receptor mediating the biological effects of irisin. • Elucidated the regulatory roles and underlying mechanisms of the irisin-integrin αVβ5 axis in multiple disease models/systems. • Establishes "exercise-irisin-integrin αVβ5" framework, supporting exercise rehabilitation’s molecular basis for disease amelioration.
No takes yet. Share an insight, caveat, or question.
Bai et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: